Manijeh Daneshmand

5.9k citations

34 papers · 3.6k indexed · 1 hit paper · h-index 18

Impact in

Oncology top 1%
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
Pulmonary and Respiratory Medicine top 2%
- Lung Cancer Treatments and Mutations

Papers in

Oncology 14
- CAR-T cell therapy research 4
- Cancer-related Molecular Pathways 3
Biotechnology 3
- Cancer Research and Treatments 3

Co-authors: Ian Lorimer Ming‐Sound Tsao John C. Bell Lesley Seymour Gilda da Cunha Santos Marlo Whitehead Suzanne Kamel‐Reid Paula Marrano
Journals: Molecular Therapy (5 papers)Oncotarget (4 papers)Journal of Clinical Oncology (3 papers)Breast Cancer Research (2 papers)Cancer Research (2 papers)
Partner nations: Canada United States South Korea

In The Last Decade

Manijeh Daneshmand

33 papers receiving 3.5k citations

Hit Papers

align trajectories log scale

Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome 2005 · 1.5k citations

Peers

Countries citing papers authored by Manijeh Daneshmand

Since Specialization

Citations

This map shows the geographic impact of Manijeh Daneshmand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manijeh Daneshmand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manijeh Daneshmand more than expected).

Fields of papers citing papers by Manijeh Daneshmand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manijeh Daneshmand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manijeh Daneshmand. The network helps show where Manijeh Daneshmand may publish in the future.

Co-authors

The 25 scholars most cited alongside Manijeh Daneshmand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Manijeh Daneshmand Line = papers co-authored together Manijeh Daneshmand links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Multiple roles for Bcl-3 in mammary gland branching, stromal collagen invasion, involution and tumor pathology Breast Cancer Research ·David Carr, Aiman A. Zein, Josée Coulombe, Tianqi Jiang, Miguel A. Cabrita, Gwendoline C. D. Ward, Manijeh Daneshmand, A. C. SAU, M.A. Christine Pratt	2022	5
2	Phosphorylated transducer and activator of transcription-3 (pSTAT3) immunohistochemical expression in paired primary and metastatic colorectal cancer Translational Oncology ·Esmeralda Celia Marginean, Joanna Gotfrit, Horia Marginean, Daniel Yokom, Justin Bateman, Manijeh Daneshmand, Shelly Sud, Allen M. Gown, Derek J. Jonker, Timothy R. Asmis, Rachel Goodwin	2020	4
3	Modulating SIRT1 activity variously affects thymic lymphoma development in mice Experimental Cell Research ·Katherine V. Clark-Knowles, Danielle Dewar‐Darch, Karen Jardine, Josée Coulombe, Manijeh Daneshmand, Xiaohong He, Michael W. McBurney	2018	1
4	cIAP2 Is an Independent Signaling and Survival Factor during Mammary Lactational Involution and Tumorigenesis Journal of Mammary Gland Biology and Neoplasia ·David Carr, Rosanna Lau, Alexandra D. Hnatykiw, Gwendoline C. D. Ward, Manijeh Daneshmand, Miguel A. Cabrita, M.A. Christine Pratt	2018	6
5	Human induced pluripotent stem cell–derived lung progenitor and alveolar epithelial cells attenuate hyperoxia-induced lung injury Cytotherapy ·Mehdi Shafa, Lavinia Ionescu, Arul Vadivel, Jennifer J.P. Collins, Liqun Xu, Shumei Zhong, Martin H. Kang, Geneviève de Caen, Manijeh Daneshmand, Jenny Shi, Katherine Z. Fu, Andrew C. Qi, Ying Wang, James Ellis, William L. Stanford, Bernard Thébaud	2017	41
6	Signal transducer and activator of transcription–3 (STAT3) expression concordance in paired primary and metastatic colorectal cancers (mCRC) Annals of Oncology ·Daniel Yokom, Shelly Sud, Horia Marginean, Timothy R. Asmis, Derek J. Jonker, Guillaume Martel, A M Gown, Manijeh Daneshmand, Esmeralda Celia Marginean, Rachel Goodwin	2016	0
7	Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity Breast Cancer Research ·Roshan K. Sriram, Vivian Lo, Benjamin R. Pryce, Lilia Antonova, Alan J. Mears, Manijeh Daneshmand, Bruce C. McKay, Simon J. Conway, William J. Muller, Luc A. Sabourin	2015	15
8	First-in-man Study of Western Reserve Strain Oncolytic Vaccinia Virus: Safety, Systemic Spread, and Antitumor Activity Molecular Therapy ·Herbert J. Zeh, Stephanie Downs‐Canner, J. Andrea McCart, Zong Sheng Guo, Uma N. M. Rao, Lekshmi Ramalingam, Stephen H. Thorne, Heather Jones, Paweł Kaliński, Eva Wieckowski, Mark E. O’Malley, Manijeh Daneshmand, Kang Hu, John C. Bell, Tae-Ho Hwang, Anne Moon, Caroline J. Breitbach, David H. Kirn, David L. Bartlett	2014	120
9	A New Spontaneously Transformed Syngeneic Model of High-Grade Serous Ovarian Cancer with a Tumor-Initiating Cell Population Frontiers in Oncology ·Curtis W. McCloskey, Reuben Goldberg, Lauren E. Carter, Lisa F. Gamwell, Ensaf M. Al-Hujaily, Olga Collins, Elizabeth A. Macdonald, Kenneth Garson, Manijeh Daneshmand, Eurı́dice Carmona, Barbara C. Vanderhyden	2014	46
10	Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans Cancer Research ·Caroline J. Breitbach, Rozanne Arulanandam, Naomi De Silva, Steve H. Thorne, Richard H. Patt, Manijeh Daneshmand, Anne Moon, Carolina S. Ilkow, James M. Burke, Tae-Ho Hwang, Jeong Heo, Mong Cho, Hannah Chen, Fernando A. Angarita, Christina Addison, J. Andrea McCart, John C. Bell, David H. Kirn	2013	208
11	PIK3CA, BRAF, and PTEN Status and Benefit from Cetuximab in the Treatment of Advanced Colorectal Cancer—Results from NCIC CTG/AGITG CO.17 Clinical Cancer Research ·Christos S. Karapetis, Derek J. Jonker, Manijeh Daneshmand, Jennifer Hanson, Christopher J. O’Callaghan, Celia Marginean, John Zalcberg, John Simes, Malcolm J. Moore, Niall C. Tebbutt, Timothy Price, Jeremy Shapiro, Nick Pavlakis, Peter Gibbs, Guy A. Van Hazel, Ursula Lee, Rashida Haq, Shakeel Virk, Dongsheng Tu, Ian A.J. Lorimer	2013	128
12	ORFV: A Novel Oncolytic and Immune Stimulating Parapoxvirus Therapeutic Molecular Therapy ·Julia L. Rintoul, Chantal G. Lemay, Lee‐Hwa Tai, Marianne M. Stanford, Theresa Falls, Christiano Tanese de Souza, Byram W. Bridle, Manijeh Daneshmand, Pamela S. Ohashi, Yonghong Wan, Brian D. Lichty, Andrew A. Mercer, Rebecca C. Auer, Harold Atkins, John C. Bell	2012	57
13	BRCA1 protein levels and PIK3CA mutations as predictive biomarkers for response to neoadjuvant chemotherapy in locally advanced breast cancer: An exploratory analysis Oncology Letters ·John Hilton, Johanne I. Weberpals, Ian Lorimer, Shahrier Amin, SM Rashed Ul Islam, Laurent Pelletier, Manijeh Daneshmand, Jennifer Hanson, Mitra Nabavi, D A E Parolin, Ranjeeta Mallick, Savita Verma	2012	3
14	BRAF, PIK3CA, and PTEN status and benefit from cetuximab (CET) in the treatment of advanced colorectal cancer (CRC): Results from NCIC CTG/AGITG CO.17. Journal of Clinical Oncology ·Derek J. Jonker, Christos S. Karapetis, Christopher J. O’Callaghan, Celia Marginean, John Zalcberg, John Simes, Malcolm J. Moore, Niall C. Tebbutt, Timothy Price, Manijeh Daneshmand, Jennifer Hanson, Jeremy Shapiro, Nick Pavlakis, Peter Gibbs, Guy A. Van Hazel, Ursula Joan Yu Min Lee, Rashida Haq, Shakeel Virk, Dongsheng Tu, Ian A.J. Lorimer	2012	2
15	Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease Clinical & Experimental Metastasis ·Michael M. Vickers, Jair Bar, Ivan Gorn‐Hondermann, Nirit Yarom, Manijeh Daneshmand, Jennifer Hanson, Christina Addison, Timothy R. Asmis, Derek J. Jonker, Jean A. Maroun, Ian Lorimer, Glenwood D. Goss, Jim Dimitroulakos	2011	99
16	A Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma Molecular Therapy ·Tae-Ho Hwang, Anne Moon, James M. Burke, Antoni Ribas, Joe Stephenson, Caroline J. Breitbach, Manijeh Daneshmand, Naomi De Silva, Kelley A. Parato, Jean‐Simon Diallo, Yeon-Sook Lee, Ta‐Chiang Liu, John C. Bell, David H. Kirn	2011	122
17	Targeting Tumor Vasculature With an Oncolytic Virus Molecular Therapy ·Caroline J. Breitbach, Naomi S. De Silva, Theresa Falls, Usaf E. Aladl, Laura Evgin, Jennifer M Paterson, Yang Sun, Dominic G. Roy, Julia L. Rintoul, Manijeh Daneshmand, Kelley A. Parato, Marianne M. Stanford, Brian D. Lichty, Aaron Fenster, David H. Kirn, Harold Atkins, John C. Bell	2011	161
18	Repression of cancer cell senescence by PKCι Oncogene ·J. Paget, Ian J. Restall, Manijeh Daneshmand, J A Mersereau, Manon A. Simard, D A E Parolin, Sylvie J. Lavictoire, Moein Amin, Shahidul Islam, Ian A.J. Lorimer	2011	24
19	Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial The Lancet Oncology ·Byeong-Ho Park, Tae-Ho Hwang, Ta‐Chiang Liu, Daniel Y. Sze, Jae‐Seok Kim, Hyuk‐Chan Kwon, Sung Yong Oh, Sang-Young Han, Jin-Han Yoon, Sook Hee Hong, Anne Moon, Kelly Speth, Chohee Park, Young-Joo Ahn, Manijeh Daneshmand, Byung Geon Rhee, Herbert M. Pinedo, John C. Bell, David H. Kirn	2008	406
20	Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome New England Journal of Medicine ·Ming‐Sound Tsao, Akira Sakurada, Jean-Claude Cutz, Chang‐Qi Zhu, Suzanne Kamel‐Reid, Jeremy A. Squire, Ian Lorimer, Tong Zhang, Ni Liu, Manijeh Daneshmand, Paula Marrano, Gilda da Cunha Santos, Alain E. Lagarde, Frank C. Richardson, Lesley Seymour, Marlo Whitehead, Keyue Ding, Joseph L. Pater, Frances A. Shepherd Hit paper breakdown →	2005	1483

About Manijeh Daneshmand

Manijeh Daneshmand is a scholar working on Oncology, Biotechnology, Cancer Research, Genetics and Pathology and Forensic Medicine, having authored 34 papers that have together received 3.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (7 papers), CAR-T cell therapy research (4 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers), Genetic factors in colorectal cancer (3 papers), Cancer Research and Treatments (3 papers), Cancer Genomics and Diagnostics (3 papers), Cancer-related Molecular Pathways (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Oncology (2.3k citations), Pulmonary and Respiratory Medicine (1.4k citations), Genetics (1.1k citations), Biotechnology (294 citations) and Cancer Research (474 citations). Manijeh Daneshmand has collaborated with scholars based in Canada, United States and South Korea. Frequent co-authors include Ian Lorimer, Ming‐Sound Tsao, John C. Bell, Lesley Seymour, Gilda da Cunha Santos, Marlo Whitehead, Suzanne Kamel‐Reid, Paula Marrano, Keyue Ding and Joseph L. Pater. Their work appears in journals such as Molecular Therapy, Oncotarget, Journal of Clinical Oncology, Breast Cancer Research and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact